Halftime Report cover image

Buy Tech’s Bounce? 2/18/25

Halftime Report

00:00

Investing in Healthcare: Gilead vs. Merck

This chapter explores investment strategies focused on healthcare stocks, specifically Gilead and Merck, emphasizing the importance of cash flow, dividends, and long-term stability. It contrasts Gilead's promising prospects with Merck's challenges while discussing market sentiment and current headlines impacting the sector.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app